These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


212 related items for PubMed ID: 22163354

  • 21. Tetrabenazine for the treatment of tardive dyskinesia.
    Leung JG, Breden EL.
    Ann Pharmacother; 2011 Apr; 45(4):525-31. PubMed ID: 21487088
    [Abstract] [Full Text] [Related]

  • 22. [Tremor].
    Raethjen J, Deuschl G.
    Ther Umsch; 2007 Jan; 64(1):35-40. PubMed ID: 17221823
    [Abstract] [Full Text] [Related]

  • 23. Treatment of levodopa-induced motor complications.
    Stocchi F, Tagliati M, Olanow CW.
    Mov Disord; 2008 Jan; 23 Suppl 3():S599-612. PubMed ID: 18781681
    [Abstract] [Full Text] [Related]

  • 24. [Update on current care guidelines. Parkinson's disease].
    Reijo M, Atula S, Heikkinen E, Jaakkola MR, Pekka J, Keränen T, Martikainen K, Pekkonen E, Sotaniemi K, Suomalaisen Lääkäriseuran Duodecimin ja Suomen Neurologisen Yhdistyksen Asettama Työryhmä.
    Duodecim; 2010 Jan; 126(19):2289-90. PubMed ID: 21086687
    [Abstract] [Full Text] [Related]

  • 25. [New methods in the pharmacotherapy of Parkinson disease].
    Nervenarzt; 1996 Nov; 67(11 Suppl Neue Strat):1-8. PubMed ID: 9402425
    [No Abstract] [Full Text] [Related]

  • 26. Future therapies for Parkinson's disease.
    Hauser RA, Lyons KE.
    Neurol Clin; 2004 Oct; 22(3 Suppl):S149-66. PubMed ID: 15501363
    [No Abstract] [Full Text] [Related]

  • 27. Setting a steady course for benign essential tremor.
    Johns Hopkins Med Lett Health After 50; 1999 Dec; 11(10):3. PubMed ID: 10586714
    [No Abstract] [Full Text] [Related]

  • 28. [Revision of the treatment strategy in Parkinson disease].
    Staal-Schreinemachers AL, Wesseling H, Lakke JP.
    Ned Tijdschr Geneeskd; 1986 May 17; 130(20):914-8. PubMed ID: 3724865
    [No Abstract] [Full Text] [Related]

  • 29. [Therapeutic use of tetrabenazine].
    López Del Val LJ, López-García E, Martínez-Martínez L, Santos-Lasaosa S.
    Rev Neurol; 1986 May 17; 48(10):523-33. PubMed ID: 19434587
    [Abstract] [Full Text] [Related]

  • 30. Tetrabenazine in the treatment of hyperkinetic movement disorders.
    Kenney C, Jankovic J.
    Expert Rev Neurother; 2006 Jan 17; 6(1):7-17. PubMed ID: 16466307
    [Abstract] [Full Text] [Related]

  • 31. Parkinson's disease.
    Imke S.
    Adv Nurse Pract; 1998 Jan 17; 6(1):24-8. PubMed ID: 9495941
    [No Abstract] [Full Text] [Related]

  • 32. Nonparkinsonism movement disorders in the elderly.
    Chen JJ, Lee KC.
    Consult Pharm; 2006 Jan 17; 21(1):58-71. PubMed ID: 16524353
    [Abstract] [Full Text] [Related]

  • 33. The treatment of tremor.
    Burton K.
    Med J Aust; 1987 Nov 16; 147(10):503-6. PubMed ID: 2891020
    [No Abstract] [Full Text] [Related]

  • 34. Adjuvant therapy of parkinsonian tremor.
    Koller WC, Herbster G.
    Arch Neurol; 1987 Sep 16; 44(9):921-3. PubMed ID: 3619710
    [Abstract] [Full Text] [Related]

  • 35. [Therapy of tparkinson's disease. Clinical and pharmacological viewpoints].
    Przuntek H.
    Med Klin; 1979 Jul 13; 74(28-29):1077-83. PubMed ID: 39230
    [No Abstract] [Full Text] [Related]

  • 36. [Drug therapy of Parkinson's disease].
    Myllylä V.
    Duodecim; 1997 Jul 13; 113(18):1827-34. PubMed ID: 10892076
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Pharmacology of Parkinson's disease.
    Burton K, Calne DB.
    Neurol Clin; 1984 Aug 13; 2(3):461-72. PubMed ID: 6152482
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.